SeqOne Score
Men/Women income difference
27/40
Differences in individual raises
25/35
% employees who had a raise after returning from maternity leave
15/15
Number of employees of the under-represented sex among the 10 highest wages
10/10
Genomics is transforming medicine at a pace the world has never seen. Sequencing costs have plummeted, access has widened, and the potential to diagnose rare diseases and target complex cancers with precision is no longer theoretical — it is here. But as data volumes grow, healthcare systems risk falling behind. The tools that bridge that gap determine which patients get answers, and how quickly.
At Congenica, we believe every patient deserves the benefit of genomic medicine, regardless of geography or healthcare system. That belief drives everything we build — scientifically rigorous, operationally deployable, and ready for the scale that modern genomic medicine demands.
Spun out of the Wellcome Sanger Institute, Congenica translates world-class genomic science into production-grade clinical care.
Now as part of SeqOne, we combine over a decade of NHS-validated pedigree with world-class advanced AI-driven architecture to deliver clinical interpretation at an unparalleled scale.
2012
SeqOne is founded in Montpellier, France, with a vision to make personalized medicine accessible to all. The company is incubated by SATT AxLR, a leading French innovation accelerator.
2015
Partnered with the 100,000 Genomes Project, establishing Congenica as a cornerstone of UK genomic medicine.
2019
SeqOne integrates AI-powered genomic analysis, optimizing its platform for greater speed, accuracy, and scalability. With over €30M in funding in a Series A round, SeqOne expands from germline testing into somatic and liquid biopsy applications, supporting advanced biomarkers such as MSI, TMB, and HRD.
2023
Named exclusive tertiary analysis partner for the Hong Kong Genome Project — a 40,000-50,000 patient initiative and Hong Kong's first large-scale genome programme. Proof that Congenica's clinical-grade platform performs beyond UK borders.
2025
Congenica joins SeqOne, bringing together 125+ talents across Cambridge, Paris, and Montpellier.
We pursue excellence relentlessly, challenging conventions and pushing boundaries to stay at the forefront of genomic innovation.
Our customers and their patients are at the heart of everything we do, driving our commitment to exceptional service and solutions.
We transform challenges into opportunities, maintaining an innovative and solution-focused mindset.
We foster transparency, accountability, and genuine collaboration in everything we do.
